To further strengthen the notion that RAP1 levels could be predictive of chemotherapy outcome, and to test the generality of our findings, we evaluated another chemotherapeutic regimen using CPT, which has been shown to be efficacious in colon cancer treatment. This evidence concerns the gene TERF2IP and malignant colon neoplasm.